LIMK1
Basic information
Region (hg38): 7:74082933-74122525
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIMK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 28 | ||||
missense | 28 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 5 | 3 | 8 | |||
non coding | 2 | |||||
Total | 0 | 0 | 28 | 30 | 6 |
Variants in LIMK1
This is a list of pathogenic ClinVar variants found in the LIMK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-74085752-C-T | Benign (Sep 19, 2018) | |||
7-74085762-G-A | not specified | Likely benign (Nov 10, 2022) | ||
7-74085792-G-C | not specified | Uncertain significance (Feb 14, 2023) | ||
7-74085819-G-A | See cases | Likely pathogenic (-) | ||
7-74085836-C-T | Likely benign (Dec 31, 2019) | |||
7-74096649-G-A | Likely benign (Jun 19, 2017) | |||
7-74096663-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
7-74096666-A-C | Benign (Dec 31, 2019) | |||
7-74096701-G-A | not specified | Uncertain significance (Jun 29, 2022) | ||
7-74096707-T-C | not specified | Uncertain significance (May 23, 2024) | ||
7-74096755-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
7-74097072-C-G | LIMK1-related disorder | Benign (Dec 31, 2019) | ||
7-74097072-C-T | Likely benign (Aug 01, 2023) | |||
7-74097127-G-A | Likely benign (Dec 12, 2017) | |||
7-74097172-G-A | Likely benign (Aug 01, 2023) | |||
7-74097180-A-G | not specified | Uncertain significance (Feb 16, 2023) | ||
7-74099063-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
7-74099179-C-T | LIMK1-related disorder | Likely benign (Dec 31, 2019) | ||
7-74099184-C-A | not specified | Uncertain significance (Oct 06, 2022) | ||
7-74099197-G-A | Likely benign (Sep 01, 2022) | |||
7-74099199-G-C | Benign (Dec 31, 2019) | |||
7-74099225-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
7-74099230-C-A | Likely benign (Jan 02, 2019) | |||
7-74099237-G-C | not specified | Uncertain significance (Nov 06, 2023) | ||
7-74099248-C-T | Benign (Apr 11, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LIMK1 | protein_coding | protein_coding | ENST00000336180 | 16 | 39593 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000629 | 125738 | 0 | 5 | 125743 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.63 | 276 | 429 | 0.643 | 0.0000283 | 4198 |
Missense in Polyphen | 84 | 168.7 | 0.49793 | 1630 | ||
Synonymous | -0.167 | 190 | 187 | 1.02 | 0.0000137 | 1277 |
Loss of Function | 4.97 | 3 | 34.5 | 0.0870 | 0.00000181 | 377 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000911 | 0.00000879 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin- 2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. Required for atypical chemokine receptor ACKR2-induced phosphorylation of cofilin (CFL1). {ECO:0000269|PubMed:10196227, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:16230460, ECO:0000269|PubMed:18028908, ECO:0000269|PubMed:23633677}.;
- Disease
- DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Axon guidance - Homo sapiens (human);Regulation of Microtubule Cytoskeleton;VEGFA-VEGFR2 Signaling Pathway;Regulation of Actin Cytoskeleton;G13 Signaling Pathway;Developmental Biology;Signal Transduction;ccr3 signaling in eosinophils;rho cell motility signaling pathway;rac1 cell motility signaling pathway;Fcgamma receptor (FCGR) dependent phagocytosis;EPH-Ephrin signaling;Innate Immune System;Immune System;EPHB-mediated forward signaling;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;RHO GTPase Effectors;Signaling by Rho GTPases;Sema4D induced cell migration and growth-cone collapse;Sema4D in semaphorin signaling;role of mal in rho-mediated activation of srf;CXCR4-mediated signaling events;Sema3A PAK dependent Axon repulsion;Semaphorin interactions;Regulation of actin dynamics for phagocytic cup formation;Axon guidance;Leptin;Caspase Cascade in Apoptosis;RAC1 signaling pathway;CDC42 signaling events;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.327
Intolerance Scores
- loftool
- 0.0812
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.88
Haploinsufficiency Scores
- pHI
- 0.309
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.452
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Limk1
- Phenotype
- cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;signal transduction;Rho protein signal transduction;nervous system development;actin cytoskeleton organization;positive regulation of actin filament bundle assembly;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of axon extension;negative regulation of ubiquitin-protein transferase activity;positive regulation of stress fiber assembly
- Cellular component
- nucleus;cytoplasm;cytosol;focal adhesion;membrane;nuclear speck;lamellipodium;neuron projection
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;heat shock protein binding;metal ion binding;protein heterodimerization activity